nodes	percent_of_prediction	percent_of_DWPC	metapath
Isoprenaline—L-DOPA—Melphalan—breast cancer	0.215	1	CrCrCtD
Isoprenaline—CYP1A1—breast cancer	0.215	1	CbGaD
Isoprenaline—CYP1A1—Toremifene—breast cancer	0.0696	0.733	CbGbCtD
Isoprenaline—CYP1A1—Tamoxifen—breast cancer	0.0254	0.268	CbGbCtD
Isoprenaline—PIK3R3—mammary gland—breast cancer	0.005	0.0545	CbGeAlD
Isoprenaline—PIK3R1—mammary gland—breast cancer	0.00427	0.0465	CbGeAlD
Isoprenaline—PIK3R1—nipple—breast cancer	0.00354	0.0385	CbGeAlD
Isoprenaline—PIK3R2—female reproductive system—breast cancer	0.00305	0.0332	CbGeAlD
Isoprenaline—ADRBK1—mammary gland—breast cancer	0.00296	0.0322	CbGeAlD
Isoprenaline—MAPK1—mammary gland—breast cancer	0.00291	0.0317	CbGeAlD
Isoprenaline—PIK3R2—female gonad—breast cancer	0.00278	0.0302	CbGeAlD
Isoprenaline—PIK3R2—endocrine gland—breast cancer	0.00258	0.0281	CbGeAlD
Isoprenaline—PIK3R3—endometrium—breast cancer	0.0025	0.0272	CbGeAlD
Isoprenaline—PIK3R3—uterus—breast cancer	0.0023	0.0251	CbGeAlD
Isoprenaline—PIK3R3—pituitary gland—breast cancer	0.00226	0.0246	CbGeAlD
Isoprenaline—PIK3R3—adipose tissue—breast cancer	0.00225	0.0245	CbGeAlD
Isoprenaline—PIK3R1—endometrium—breast cancer	0.00213	0.0232	CbGeAlD
Isoprenaline—PIK3R3—female reproductive system—breast cancer	0.00207	0.0225	CbGeAlD
Isoprenaline—PIK3R3—adrenal gland—breast cancer	0.00202	0.022	CbGeAlD
Isoprenaline—ADRBK1—embryo—breast cancer	0.00202	0.022	CbGeAlD
Isoprenaline—MAPK1—embryo—breast cancer	0.00199	0.0217	CbGeAlD
Isoprenaline—PIK3R1—uterus—breast cancer	0.00197	0.0214	CbGeAlD
Isoprenaline—PIK3R1—pituitary gland—breast cancer	0.00193	0.021	CbGeAlD
Isoprenaline—PIK3R1—adipose tissue—breast cancer	0.00192	0.0209	CbGeAlD
Isoprenaline—PIK3R3—female gonad—breast cancer	0.00188	0.0205	CbGeAlD
Isoprenaline—PIK3R3—endocrine gland—breast cancer	0.00175	0.0191	CbGeAlD
Isoprenaline—PIK3R1—adrenal gland—breast cancer	0.00173	0.0188	CbGeAlD
Isoprenaline—PIK3R1—bone marrow—breast cancer	0.00167	0.0182	CbGeAlD
Isoprenaline—MAPK1—epithelium—breast cancer	0.00162	0.0177	CbGeAlD
Isoprenaline—PIK3R1—female gonad—breast cancer	0.00161	0.0175	CbGeAlD
Isoprenaline—MAPK1—skin of body—breast cancer	0.00154	0.0168	CbGeAlD
Isoprenaline—ADRB3—adipose tissue—breast cancer	0.00136	0.0148	CbGeAlD
Isoprenaline—MAPK1—uterus—breast cancer	0.00134	0.0146	CbGeAlD
Isoprenaline—ADRBK1—adipose tissue—breast cancer	0.00133	0.0145	CbGeAlD
Isoprenaline—MAPK1—adipose tissue—breast cancer	0.00131	0.0143	CbGeAlD
Isoprenaline—ADRB3—female reproductive system—breast cancer	0.00125	0.0136	CbGeAlD
Isoprenaline—ADRBK1—female reproductive system—breast cancer	0.00122	0.0133	CbGeAlD
Isoprenaline—PIK3R3—lymph node—breast cancer	0.00121	0.0132	CbGeAlD
Isoprenaline—MAPK1—female reproductive system—breast cancer	0.00121	0.0131	CbGeAlD
Isoprenaline—ADRBK1—adrenal gland—breast cancer	0.00119	0.013	CbGeAlD
Isoprenaline—MAPK1—adrenal gland—breast cancer	0.00118	0.0128	CbGeAlD
Isoprenaline—ADRBK1—bone marrow—breast cancer	0.00116	0.0126	CbGeAlD
Isoprenaline—ADRB3—female gonad—breast cancer	0.00114	0.0124	CbGeAlD
Isoprenaline—MAPK1—bone marrow—breast cancer	0.00114	0.0124	CbGeAlD
Isoprenaline—ADRBK1—female gonad—breast cancer	0.00111	0.0121	CbGeAlD
Isoprenaline—MAPK1—female gonad—breast cancer	0.0011	0.0119	CbGeAlD
Isoprenaline—ADRBK1—endocrine gland—breast cancer	0.00104	0.0113	CbGeAlD
Isoprenaline—PIK3R1—lymph node—breast cancer	0.00103	0.0113	CbGeAlD
Isoprenaline—Masoprocol—IGF1R—breast cancer	0.00103	0.293	CrCbGaD
Isoprenaline—MAPK1—endocrine gland—breast cancer	0.00102	0.0111	CbGeAlD
Isoprenaline—ADRBK1—lymph node—breast cancer	0.000716	0.00779	CbGeAlD
Isoprenaline—MAPK1—lymph node—breast cancer	0.000705	0.00768	CbGeAlD
Isoprenaline—CYP1A1—nipple—breast cancer	0.00066	0.00718	CbGeAlD
Isoprenaline—ADRB1—adipose tissue—breast cancer	0.000557	0.00606	CbGeAlD
Isoprenaline—ADRB1—female reproductive system—breast cancer	0.000512	0.00557	CbGeAlD
Isoprenaline—Methyldopa—COMT—breast cancer	0.000462	0.131	CrCbGaD
Isoprenaline—CYP1A1—epithelium—breast cancer	0.000444	0.00484	CbGeAlD
Isoprenaline—ADRB1—endocrine gland—breast cancer	0.000433	0.00471	CbGeAlD
Isoprenaline—CYP1A1—skin of body—breast cancer	0.000423	0.0046	CbGeAlD
Isoprenaline—Terbutaline—BCHE—breast cancer	0.000408	0.116	CrCbGaD
Isoprenaline—Nausea—Lapatinib—breast cancer	0.000369	0.00357	CcSEcCtD
Isoprenaline—Pulmonary oedema—Docetaxel—breast cancer	0.000367	0.00355	CcSEcCtD
Isoprenaline—CYP1A1—uterus—breast cancer	0.000367	0.004	CbGeAlD
Isoprenaline—Angina pectoris—Irinotecan—breast cancer	0.000365	0.00353	CcSEcCtD
Isoprenaline—Arrhythmia—Goserelin—breast cancer	0.000363	0.0035	CcSEcCtD
Isoprenaline—Convulsion—Chlorambucil—breast cancer	0.00036	0.00348	CcSEcCtD
Isoprenaline—CYP1A1—adipose tissue—breast cancer	0.000359	0.00391	CbGeAlD
Isoprenaline—Bronchospasm—Gemcitabine—breast cancer	0.000359	0.00347	CcSEcCtD
Isoprenaline—Headache—Fulvestrant—breast cancer	0.000358	0.00346	CcSEcCtD
Isoprenaline—Asthenia—Exemestane—breast cancer	0.000356	0.00344	CcSEcCtD
Isoprenaline—Headache—Toremifene—breast cancer	0.000354	0.00342	CcSEcCtD
Isoprenaline—Angina pectoris—Fluorouracil—breast cancer	0.000349	0.00338	CcSEcCtD
Isoprenaline—Ventricular arrhythmia—Doxorubicin—breast cancer	0.000348	0.00336	CcSEcCtD
Isoprenaline—Tension—Goserelin—breast cancer	0.000347	0.00335	CcSEcCtD
Isoprenaline—Nervousness—Goserelin—breast cancer	0.000343	0.00332	CcSEcCtD
Isoprenaline—Vertigo—Vinblastine—breast cancer	0.000342	0.00331	CcSEcCtD
Isoprenaline—Nausea—Fulvestrant—breast cancer	0.00034	0.00328	CcSEcCtD
Isoprenaline—Flushing—Vinorelbine—breast cancer	0.000337	0.00326	CcSEcCtD
Isoprenaline—Asthenia—Ixabepilone—breast cancer	0.000336	0.00325	CcSEcCtD
Isoprenaline—Cardiac arrest—Paclitaxel—breast cancer	0.000336	0.00325	CcSEcCtD
Isoprenaline—Nausea—Toremifene—breast cancer	0.000335	0.00324	CcSEcCtD
Isoprenaline—Vision blurred—Goserelin—breast cancer	0.000333	0.00322	CcSEcCtD
Isoprenaline—CYP1A1—female reproductive system—breast cancer	0.00033	0.00359	CbGeAlD
Isoprenaline—Convulsion—Vinblastine—breast cancer	0.00033	0.00319	CcSEcCtD
Isoprenaline—Hypertension—Vinblastine—breast cancer	0.000329	0.00318	CcSEcCtD
Isoprenaline—Dizziness—Exemestane—breast cancer	0.000328	0.00317	CcSEcCtD
Isoprenaline—Masoprocol—CYP19A1—breast cancer	0.000327	0.0927	CrCbGaD
Isoprenaline—Arrhythmia—Vinorelbine—breast cancer	0.000325	0.00314	CcSEcCtD
Isoprenaline—Sweating—Irinotecan—breast cancer	0.00032	0.00309	CcSEcCtD
Isoprenaline—Sweating—Mitoxantrone—breast cancer	0.00032	0.00309	CcSEcCtD
Isoprenaline—Hypertension—Tamoxifen—breast cancer	0.000319	0.00309	CcSEcCtD
Isoprenaline—Asthenia—Anastrozole—breast cancer	0.000317	0.00306	CcSEcCtD
Isoprenaline—Asthenia—Letrozole—breast cancer	0.000317	0.00306	CcSEcCtD
Isoprenaline—Convulsion—Melphalan—breast cancer	0.000314	0.00303	CcSEcCtD
Isoprenaline—Palpitations—Goserelin—breast cancer	0.000312	0.00302	CcSEcCtD
Isoprenaline—Sweating—Gemcitabine—breast cancer	0.000312	0.00301	CcSEcCtD
Isoprenaline—Headache—Exemestane—breast cancer	0.000311	0.00301	CcSEcCtD
Isoprenaline—Arrhythmia—Thiotepa—breast cancer	0.00031	0.003	CcSEcCtD
Isoprenaline—Dizziness—Ixabepilone—breast cancer	0.00031	0.00299	CcSEcCtD
Isoprenaline—Convulsion—Goserelin—breast cancer	0.000306	0.00296	CcSEcCtD
Isoprenaline—Hypertension—Goserelin—breast cancer	0.000305	0.00295	CcSEcCtD
Isoprenaline—CYP1A1—female gonad—breast cancer	0.0003	0.00327	CbGeAlD
Isoprenaline—Tension—Thiotepa—breast cancer	0.000297	0.00287	CcSEcCtD
Isoprenaline—Nausea—Exemestane—breast cancer	0.000295	0.00285	CcSEcCtD
Isoprenaline—Nervousness—Thiotepa—breast cancer	0.000294	0.00284	CcSEcCtD
Isoprenaline—Headache—Ixabepilone—breast cancer	0.000294	0.00284	CcSEcCtD
Isoprenaline—Hyperhidrosis—Tamoxifen—breast cancer	0.000292	0.00282	CcSEcCtD
Isoprenaline—Dizziness—Letrozole—breast cancer	0.000292	0.00282	CcSEcCtD
Isoprenaline—Dizziness—Anastrozole—breast cancer	0.000292	0.00282	CcSEcCtD
Isoprenaline—Tachycardia—Melphalan—breast cancer	0.000289	0.00279	CcSEcCtD
Isoprenaline—Vision blurred—Thiotepa—breast cancer	0.000285	0.00275	CcSEcCtD
Isoprenaline—Vertigo—Vinorelbine—breast cancer	0.000284	0.00275	CcSEcCtD
Isoprenaline—Tachycardia—Goserelin—breast cancer	0.000281	0.00272	CcSEcCtD
Isoprenaline—Palpitations—Vinorelbine—breast cancer	0.00028	0.0027	CcSEcCtD
Isoprenaline—CYP1A1—endocrine gland—breast cancer	0.000279	0.00304	CbGeAlD
Isoprenaline—Hyperhidrosis—Goserelin—breast cancer	0.000279	0.00269	CcSEcCtD
Isoprenaline—Nausea—Ixabepilone—breast cancer	0.000278	0.00269	CcSEcCtD
Isoprenaline—Flushing—Irinotecan—breast cancer	0.000278	0.00269	CcSEcCtD
Isoprenaline—Dizziness—Raloxifene—breast cancer	0.000277	0.00268	CcSEcCtD
Isoprenaline—Headache—Anastrozole—breast cancer	0.000276	0.00267	CcSEcCtD
Isoprenaline—Headache—Letrozole—breast cancer	0.000276	0.00267	CcSEcCtD
Isoprenaline—Hypotension—Melphalan—breast cancer	0.000276	0.00267	CcSEcCtD
Isoprenaline—Cardiac arrest—Capecitabine—breast cancer	0.000276	0.00266	CcSEcCtD
Isoprenaline—Hypertension—Vinorelbine—breast cancer	0.000273	0.00264	CcSEcCtD
Isoprenaline—Insomnia—Tamoxifen—breast cancer	0.000273	0.00264	CcSEcCtD
Isoprenaline—Hypotension—Goserelin—breast cancer	0.000269	0.0026	CcSEcCtD
Isoprenaline—Dyspnoea—Tamoxifen—breast cancer	0.000269	0.0026	CcSEcCtD
Isoprenaline—Arrhythmia—Mitoxantrone—breast cancer	0.000268	0.00259	CcSEcCtD
Isoprenaline—Arrhythmia—Irinotecan—breast cancer	0.000268	0.00259	CcSEcCtD
Isoprenaline—Pulmonary oedema—Methotrexate—breast cancer	0.000265	0.00256	CcSEcCtD
Isoprenaline—Dyspnoea—Melphalan—breast cancer	0.000264	0.00255	CcSEcCtD
Isoprenaline—Headache—Raloxifene—breast cancer	0.000262	0.00253	CcSEcCtD
Isoprenaline—Headache—Idarubicin—breast cancer	0.000262	0.00253	CcSEcCtD
Isoprenaline—Nausea—Anastrozole—breast cancer	0.000262	0.00253	CcSEcCtD
Isoprenaline—Nausea—Letrozole—breast cancer	0.000262	0.00253	CcSEcCtD
Isoprenaline—Convulsion—Thiotepa—breast cancer	0.000262	0.00253	CcSEcCtD
Isoprenaline—Hypertension—Thiotepa—breast cancer	0.000261	0.00252	CcSEcCtD
Isoprenaline—Arrhythmia—Gemcitabine—breast cancer	0.000261	0.00252	CcSEcCtD
Isoprenaline—Insomnia—Goserelin—breast cancer	0.000261	0.00252	CcSEcCtD
Isoprenaline—Dyspnoea—Goserelin—breast cancer	0.000257	0.00248	CcSEcCtD
Isoprenaline—Arrhythmia—Fluorouracil—breast cancer	0.000257	0.00248	CcSEcCtD
Isoprenaline—Bronchospasm—Docetaxel—breast cancer	0.000255	0.00246	CcSEcCtD
Isoprenaline—Angina pectoris—Docetaxel—breast cancer	0.000252	0.00244	CcSEcCtD
Isoprenaline—Tachycardia—Vinorelbine—breast cancer	0.000252	0.00244	CcSEcCtD
Isoprenaline—Nausea—Raloxifene—breast cancer	0.000249	0.0024	CcSEcCtD
Isoprenaline—Nausea—Idarubicin—breast cancer	0.000249	0.0024	CcSEcCtD
Isoprenaline—Pulmonary oedema—Epirubicin—breast cancer	0.000248	0.00239	CcSEcCtD
Isoprenaline—Bronchospasm—Capecitabine—breast cancer	0.000247	0.00238	CcSEcCtD
Isoprenaline—Vision blurred—Mitoxantrone—breast cancer	0.000246	0.00238	CcSEcCtD
Isoprenaline—Angina pectoris—Capecitabine—breast cancer	0.000244	0.00236	CcSEcCtD
Isoprenaline—Asthenia—Chlorambucil—breast cancer	0.000243	0.00235	CcSEcCtD
Isoprenaline—Hypotension—Vinorelbine—breast cancer	0.000241	0.00233	CcSEcCtD
Isoprenaline—Tachycardia—Thiotepa—breast cancer	0.000241	0.00233	CcSEcCtD
Isoprenaline—Vision blurred—Fluorouracil—breast cancer	0.000236	0.00228	CcSEcCtD
Isoprenaline—Vertigo—Irinotecan—breast cancer	0.000235	0.00227	CcSEcCtD
Isoprenaline—Dyspnoea—Vinorelbine—breast cancer	0.00023	0.00222	CcSEcCtD
Isoprenaline—Pulmonary oedema—Doxorubicin—breast cancer	0.000229	0.00222	CcSEcCtD
Isoprenaline—Flushing—Paclitaxel—breast cancer	0.000227	0.00219	CcSEcCtD
Isoprenaline—Convulsion—Mitoxantrone—breast cancer	0.000226	0.00218	CcSEcCtD
Isoprenaline—Dopamine—COMT—breast cancer	0.000225	0.0639	CrCbGaD
Isoprenaline—Hypertension—Mitoxantrone—breast cancer	0.000225	0.00218	CcSEcCtD
Isoprenaline—Hypertension—Irinotecan—breast cancer	0.000225	0.00218	CcSEcCtD
Isoprenaline—Asthenia—Vinblastine—breast cancer	0.000223	0.00215	CcSEcCtD
Isoprenaline—Hypertension—Gemcitabine—breast cancer	0.00022	0.00212	CcSEcCtD
Isoprenaline—Arrhythmia—Paclitaxel—breast cancer	0.000218	0.00211	CcSEcCtD
Isoprenaline—Asthenia—Tamoxifen—breast cancer	0.000217	0.00209	CcSEcCtD
Isoprenaline—Convulsion—Fluorouracil—breast cancer	0.000217	0.00209	CcSEcCtD
Isoprenaline—Asthenia—Melphalan—breast cancer	0.000212	0.00205	CcSEcCtD
Isoprenaline—Tension—Paclitaxel—breast cancer	0.000209	0.00202	CcSEcCtD
Isoprenaline—Tachycardia—Mitoxantrone—breast cancer	0.000208	0.00201	CcSEcCtD
Isoprenaline—Asthenia—Goserelin—breast cancer	0.000207	0.002	CcSEcCtD
Isoprenaline—Nervousness—Paclitaxel—breast cancer	0.000207	0.002	CcSEcCtD
Isoprenaline—Hyperhidrosis—Mitoxantrone—breast cancer	0.000206	0.00199	CcSEcCtD
Isoprenaline—Hyperhidrosis—Irinotecan—breast cancer	0.000206	0.00199	CcSEcCtD
Isoprenaline—Dizziness—Vinblastine—breast cancer	0.000206	0.00199	CcSEcCtD
Isoprenaline—Nausea—Chlorambucil—breast cancer	0.000201	0.00195	CcSEcCtD
Isoprenaline—Vision blurred—Paclitaxel—breast cancer	0.000201	0.00194	CcSEcCtD
Isoprenaline—Hyperhidrosis—Gemcitabine—breast cancer	0.000201	0.00194	CcSEcCtD
Isoprenaline—Dizziness—Tamoxifen—breast cancer	0.0002	0.00193	CcSEcCtD
Isoprenaline—Tremor—Paclitaxel—breast cancer	0.000199	0.00193	CcSEcCtD
Isoprenaline—Tachycardia—Fluorouracil—breast cancer	0.000199	0.00192	CcSEcCtD
Isoprenaline—Hypotension—Irinotecan—breast cancer	0.000199	0.00192	CcSEcCtD
Isoprenaline—Hypotension—Mitoxantrone—breast cancer	0.000199	0.00192	CcSEcCtD
Isoprenaline—Headache—Vinblastine—breast cancer	0.000195	0.00188	CcSEcCtD
Isoprenaline—Hypotension—Gemcitabine—breast cancer	0.000194	0.00187	CcSEcCtD
Isoprenaline—CYP1A1—lymph node—breast cancer	0.000193	0.0021	CbGeAlD
Isoprenaline—Insomnia—Irinotecan—breast cancer	0.000193	0.00186	CcSEcCtD
Isoprenaline—Flushing—Docetaxel—breast cancer	0.000192	0.00186	CcSEcCtD
Isoprenaline—Cardiac arrest—Epirubicin—breast cancer	0.000192	0.00186	CcSEcCtD
Isoprenaline—Vertigo—Paclitaxel—breast cancer	0.000191	0.00185	CcSEcCtD
Isoprenaline—Dizziness—Goserelin—breast cancer	0.000191	0.00184	CcSEcCtD
Isoprenaline—Hypotension—Fluorouracil—breast cancer	0.000191	0.00184	CcSEcCtD
Isoprenaline—Dyspnoea—Mitoxantrone—breast cancer	0.00019	0.00183	CcSEcCtD
Isoprenaline—Dyspnoea—Irinotecan—breast cancer	0.00019	0.00183	CcSEcCtD
Isoprenaline—Headache—Tamoxifen—breast cancer	0.000189	0.00183	CcSEcCtD
Isoprenaline—Palpitations—Paclitaxel—breast cancer	0.000188	0.00182	CcSEcCtD
Isoprenaline—Insomnia—Gemcitabine—breast cancer	0.000188	0.00181	CcSEcCtD
Isoprenaline—Flushing—Capecitabine—breast cancer	0.000186	0.0018	CcSEcCtD
Isoprenaline—Asthenia—Vinorelbine—breast cancer	0.000185	0.00179	CcSEcCtD
Isoprenaline—Arrhythmia—Docetaxel—breast cancer	0.000185	0.00179	CcSEcCtD
Isoprenaline—Dyspnoea—Gemcitabine—breast cancer	0.000185	0.00179	CcSEcCtD
Isoprenaline—Nausea—Vinblastine—breast cancer	0.000185	0.00178	CcSEcCtD
Isoprenaline—Insomnia—Fluorouracil—breast cancer	0.000185	0.00178	CcSEcCtD
Isoprenaline—Convulsion—Paclitaxel—breast cancer	0.000184	0.00178	CcSEcCtD
Isoprenaline—Hypertension—Paclitaxel—breast cancer	0.000184	0.00178	CcSEcCtD
Isoprenaline—Dyspnoea—Fluorouracil—breast cancer	0.000182	0.00176	CcSEcCtD
Isoprenaline—Headache—Goserelin—breast cancer	0.000181	0.00175	CcSEcCtD
Isoprenaline—Nausea—Tamoxifen—breast cancer	0.000179	0.00173	CcSEcCtD
Isoprenaline—Arrhythmia—Capecitabine—breast cancer	0.000179	0.00173	CcSEcCtD
Isoprenaline—Cardiac arrest—Doxorubicin—breast cancer	0.000178	0.00172	CcSEcCtD
Isoprenaline—Asthenia—Thiotepa—breast cancer	0.000177	0.00171	CcSEcCtD
Isoprenaline—Nausea—Melphalan—breast cancer	0.000176	0.0017	CcSEcCtD
Isoprenaline—Nausea—Goserelin—breast cancer	0.000171	0.00166	CcSEcCtD
Isoprenaline—Dizziness—Vinorelbine—breast cancer	0.000171	0.00165	CcSEcCtD
Isoprenaline—Angina pectoris—Epirubicin—breast cancer	0.00017	0.00164	CcSEcCtD
Isoprenaline—Tachycardia—Paclitaxel—breast cancer	0.00017	0.00164	CcSEcCtD
Isoprenaline—Hyperhidrosis—Paclitaxel—breast cancer	0.000168	0.00162	CcSEcCtD
Isoprenaline—Arformoterol—CYP2D6—breast cancer	0.000166	0.0472	CrCbGaD
Isoprenaline—Formoterol—CYP2D6—breast cancer	0.000166	0.0472	CrCbGaD
Isoprenaline—Vision blurred—Capecitabine—breast cancer	0.000165	0.00159	CcSEcCtD
Isoprenaline—Tremor—Capecitabine—breast cancer	0.000164	0.00158	CcSEcCtD
Isoprenaline—Dizziness—Thiotepa—breast cancer	0.000163	0.00158	CcSEcCtD
Isoprenaline—Hypotension—Paclitaxel—breast cancer	0.000162	0.00157	CcSEcCtD
Isoprenaline—Headache—Vinorelbine—breast cancer	0.000162	0.00156	CcSEcCtD
Isoprenaline—Sweating—Methotrexate—breast cancer	0.00016	0.00154	CcSEcCtD
Isoprenaline—Palpitations—Docetaxel—breast cancer	0.000159	0.00154	CcSEcCtD
Isoprenaline—Angina pectoris—Doxorubicin—breast cancer	0.000157	0.00152	CcSEcCtD
Isoprenaline—Insomnia—Paclitaxel—breast cancer	0.000157	0.00152	CcSEcCtD
Isoprenaline—Vertigo—Capecitabine—breast cancer	0.000157	0.00152	CcSEcCtD
Isoprenaline—Convulsion—Docetaxel—breast cancer	0.000156	0.00151	CcSEcCtD
Isoprenaline—Hypertension—Docetaxel—breast cancer	0.000156	0.00151	CcSEcCtD
Isoprenaline—Dyspnoea—Paclitaxel—breast cancer	0.000155	0.0015	CcSEcCtD
Isoprenaline—Headache—Thiotepa—breast cancer	0.000155	0.00149	CcSEcCtD
Isoprenaline—Palpitations—Capecitabine—breast cancer	0.000154	0.00149	CcSEcCtD
Isoprenaline—Nausea—Vinorelbine—breast cancer	0.000153	0.00148	CcSEcCtD
Isoprenaline—Asthenia—Mitoxantrone—breast cancer	0.000153	0.00148	CcSEcCtD
Isoprenaline—Asthenia—Irinotecan—breast cancer	0.000153	0.00148	CcSEcCtD
Isoprenaline—Hypertension—Capecitabine—breast cancer	0.000151	0.00146	CcSEcCtD
Isoprenaline—Sweating—Epirubicin—breast cancer	0.000149	0.00144	CcSEcCtD
Isoprenaline—Asthenia—Gemcitabine—breast cancer	0.000149	0.00144	CcSEcCtD
Isoprenaline—Nausea—Thiotepa—breast cancer	0.000147	0.00142	CcSEcCtD
Isoprenaline—Tachycardia—Docetaxel—breast cancer	0.000144	0.00139	CcSEcCtD
Isoprenaline—Salbutamol—CYP3A4—breast cancer	0.000143	0.0405	CrCbGaD
Isoprenaline—Dizziness—Irinotecan—breast cancer	0.000141	0.00136	CcSEcCtD
Isoprenaline—Tachycardia—Capecitabine—breast cancer	0.000139	0.00134	CcSEcCtD
Isoprenaline—Sweating—Doxorubicin—breast cancer	0.000138	0.00133	CcSEcCtD
Isoprenaline—Hyperhidrosis—Capecitabine—breast cancer	0.000138	0.00133	CcSEcCtD
Isoprenaline—Hypotension—Docetaxel—breast cancer	0.000138	0.00133	CcSEcCtD
Isoprenaline—Dizziness—Fluorouracil—breast cancer	0.000135	0.0013	CcSEcCtD
Isoprenaline—Headache—Irinotecan—breast cancer	0.000133	0.00129	CcSEcCtD
Isoprenaline—Headache—Mitoxantrone—breast cancer	0.000133	0.00129	CcSEcCtD
Isoprenaline—Hypotension—Capecitabine—breast cancer	0.000133	0.00129	CcSEcCtD
Isoprenaline—Insomnia—Docetaxel—breast cancer	0.000133	0.00129	CcSEcCtD
Isoprenaline—Epinephrine—TNF—breast cancer	0.000133	0.0377	CrCbGaD
Isoprenaline—Dyspnoea—Docetaxel—breast cancer	0.000131	0.00127	CcSEcCtD
Isoprenaline—Headache—Gemcitabine—breast cancer	0.00013	0.00126	CcSEcCtD
Isoprenaline—Flushing—Epirubicin—breast cancer	0.00013	0.00125	CcSEcCtD
Isoprenaline—Insomnia—Capecitabine—breast cancer	0.000129	0.00125	CcSEcCtD
Isoprenaline—Headache—Fluorouracil—breast cancer	0.000128	0.00123	CcSEcCtD
Isoprenaline—Dyspnoea—Capecitabine—breast cancer	0.000127	0.00123	CcSEcCtD
Isoprenaline—Nausea—Irinotecan—breast cancer	0.000127	0.00122	CcSEcCtD
Isoprenaline—Nausea—Mitoxantrone—breast cancer	0.000127	0.00122	CcSEcCtD
Isoprenaline—Arrhythmia—Epirubicin—breast cancer	0.000125	0.00121	CcSEcCtD
Isoprenaline—Asthenia—Paclitaxel—breast cancer	0.000125	0.0012	CcSEcCtD
Isoprenaline—Nausea—Gemcitabine—breast cancer	0.000123	0.00119	CcSEcCtD
Isoprenaline—Vision blurred—Methotrexate—breast cancer	0.000123	0.00118	CcSEcCtD
Isoprenaline—Labetalol—CYP2D6—breast cancer	0.000122	0.0345	CrCbGaD
Isoprenaline—Nausea—Fluorouracil—breast cancer	0.000121	0.00117	CcSEcCtD
Isoprenaline—Flushing—Doxorubicin—breast cancer	0.00012	0.00116	CcSEcCtD
Isoprenaline—Tension—Epirubicin—breast cancer	0.000119	0.00115	CcSEcCtD
Isoprenaline—Nervousness—Epirubicin—breast cancer	0.000118	0.00114	CcSEcCtD
Isoprenaline—Vertigo—Methotrexate—breast cancer	0.000117	0.00113	CcSEcCtD
Isoprenaline—Pindolol—CYP2D6—breast cancer	0.000117	0.0331	CrCbGaD
Isoprenaline—Arrhythmia—Doxorubicin—breast cancer	0.000116	0.00112	CcSEcCtD
Isoprenaline—Dizziness—Paclitaxel—breast cancer	0.000115	0.00111	CcSEcCtD
Isoprenaline—Vision blurred—Epirubicin—breast cancer	0.000115	0.00111	CcSEcCtD
Isoprenaline—Convulsion—Methotrexate—breast cancer	0.000113	0.00109	CcSEcCtD
Isoprenaline—Tension—Doxorubicin—breast cancer	0.000111	0.00107	CcSEcCtD
Isoprenaline—Nervousness—Doxorubicin—breast cancer	0.000109	0.00106	CcSEcCtD
Isoprenaline—Vertigo—Epirubicin—breast cancer	0.000109	0.00106	CcSEcCtD
Isoprenaline—Headache—Paclitaxel—breast cancer	0.000109	0.00105	CcSEcCtD
Isoprenaline—Palpitations—Epirubicin—breast cancer	0.000108	0.00104	CcSEcCtD
Isoprenaline—Vision blurred—Doxorubicin—breast cancer	0.000106	0.00103	CcSEcCtD
Isoprenaline—Asthenia—Docetaxel—breast cancer	0.000106	0.00102	CcSEcCtD
Isoprenaline—Convulsion—Epirubicin—breast cancer	0.000105	0.00102	CcSEcCtD
Isoprenaline—Hypertension—Epirubicin—breast cancer	0.000105	0.00102	CcSEcCtD
Isoprenaline—Nausea—Paclitaxel—breast cancer	0.000103	0.000997	CcSEcCtD
Isoprenaline—Hyperhidrosis—Methotrexate—breast cancer	0.000103	0.000991	CcSEcCtD
Isoprenaline—Asthenia—Capecitabine—breast cancer	0.000102	0.000988	CcSEcCtD
Isoprenaline—Vertigo—Doxorubicin—breast cancer	0.000101	0.000977	CcSEcCtD
Isoprenaline—Palpitations—Doxorubicin—breast cancer	9.95e-05	0.000961	CcSEcCtD
Isoprenaline—Hypotension—Methotrexate—breast cancer	9.92e-05	0.000958	CcSEcCtD
Isoprenaline—Convulsion—Doxorubicin—breast cancer	9.76e-05	0.000943	CcSEcCtD
Isoprenaline—Dizziness—Docetaxel—breast cancer	9.74e-05	0.000941	CcSEcCtD
Isoprenaline—Hypertension—Doxorubicin—breast cancer	9.72e-05	0.000939	CcSEcCtD
Isoprenaline—Tachycardia—Epirubicin—breast cancer	9.69e-05	0.000937	CcSEcCtD
Isoprenaline—Hyperhidrosis—Epirubicin—breast cancer	9.6e-05	0.000928	CcSEcCtD
Isoprenaline—Insomnia—Methotrexate—breast cancer	9.6e-05	0.000927	CcSEcCtD
Isoprenaline—Dyspnoea—Methotrexate—breast cancer	9.46e-05	0.000914	CcSEcCtD
Isoprenaline—Dizziness—Capecitabine—breast cancer	9.43e-05	0.000911	CcSEcCtD
Isoprenaline—Hypotension—Epirubicin—breast cancer	9.28e-05	0.000897	CcSEcCtD
Isoprenaline—Headache—Docetaxel—breast cancer	9.23e-05	0.000891	CcSEcCtD
Isoprenaline—Insomnia—Epirubicin—breast cancer	8.98e-05	0.000868	CcSEcCtD
Isoprenaline—Tachycardia—Doxorubicin—breast cancer	8.97e-05	0.000867	CcSEcCtD
Isoprenaline—Headache—Capecitabine—breast cancer	8.93e-05	0.000863	CcSEcCtD
Isoprenaline—Hyperhidrosis—Doxorubicin—breast cancer	8.88e-05	0.000858	CcSEcCtD
Isoprenaline—Dyspnoea—Epirubicin—breast cancer	8.86e-05	0.000856	CcSEcCtD
Isoprenaline—Nausea—Docetaxel—breast cancer	8.75e-05	0.000845	CcSEcCtD
Isoprenaline—Hypotension—Doxorubicin—breast cancer	8.59e-05	0.00083	CcSEcCtD
Isoprenaline—Nausea—Capecitabine—breast cancer	8.47e-05	0.000818	CcSEcCtD
Isoprenaline—Insomnia—Doxorubicin—breast cancer	8.31e-05	0.000803	CcSEcCtD
Isoprenaline—L-DOPA—CYP2D6—breast cancer	8.28e-05	0.0235	CrCbGaD
Isoprenaline—Dyspnoea—Doxorubicin—breast cancer	8.19e-05	0.000792	CcSEcCtD
Isoprenaline—Dopamine—CYP2D6—breast cancer	7.7e-05	0.0218	CrCbGaD
Isoprenaline—Asthenia—Methotrexate—breast cancer	7.62e-05	0.000736	CcSEcCtD
Isoprenaline—Asthenia—Epirubicin—breast cancer	7.13e-05	0.000689	CcSEcCtD
Isoprenaline—Dizziness—Methotrexate—breast cancer	7.02e-05	0.000678	CcSEcCtD
Isoprenaline—Headache—Methotrexate—breast cancer	6.65e-05	0.000642	CcSEcCtD
Isoprenaline—Asthenia—Doxorubicin—breast cancer	6.59e-05	0.000637	CcSEcCtD
Isoprenaline—Dizziness—Epirubicin—breast cancer	6.57e-05	0.000635	CcSEcCtD
Isoprenaline—Epinephrine—CYP3A4—breast cancer	6.45e-05	0.0183	CrCbGaD
Isoprenaline—Nausea—Methotrexate—breast cancer	6.3e-05	0.000609	CcSEcCtD
Isoprenaline—Headache—Epirubicin—breast cancer	6.22e-05	0.000601	CcSEcCtD
Isoprenaline—Dizziness—Doxorubicin—breast cancer	6.08e-05	0.000587	CcSEcCtD
Isoprenaline—Nausea—Epirubicin—breast cancer	5.9e-05	0.00057	CcSEcCtD
Isoprenaline—Headache—Doxorubicin—breast cancer	5.76e-05	0.000556	CcSEcCtD
Isoprenaline—Nausea—Doxorubicin—breast cancer	5.46e-05	0.000527	CcSEcCtD
Isoprenaline—ADRB3—Signaling Pathways—CDKN1A—breast cancer	1.32e-06	4.8e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MAPK8—breast cancer	1.32e-06	4.8e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—PTEN—breast cancer	1.32e-06	4.79e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling by GPCR—AKT1—breast cancer	1.32e-06	4.79e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—SRC—breast cancer	1.32e-06	4.78e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—CDKN1A—breast cancer	1.32e-06	4.77e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—HIF1A—breast cancer	1.31e-06	4.77e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—PTEN—breast cancer	1.31e-06	4.76e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—LEP—breast cancer	1.31e-06	4.76e-06	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—IL6—breast cancer	1.31e-06	4.75e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—IL6—breast cancer	1.31e-06	4.74e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—BRAF—breast cancer	1.31e-06	4.74e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CAV1—breast cancer	1.3e-06	4.71e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MAPK8—breast cancer	1.29e-06	4.69e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling by GPCR—AKT1—breast cancer	1.29e-06	4.67e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—KDR—breast cancer	1.29e-06	4.66e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—LEP—breast cancer	1.28e-06	4.65e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—KRAS—breast cancer	1.28e-06	4.65e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ABCB1—breast cancer	1.28e-06	4.64e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—STAT3—breast cancer	1.27e-06	4.61e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IGF1—breast cancer	1.27e-06	4.61e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CAV1—breast cancer	1.27e-06	4.61e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—AKT2—breast cancer	1.27e-06	4.61e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—EGFR—breast cancer	1.27e-06	4.59e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—KRAS—breast cancer	1.26e-06	4.58e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—HRAS—breast cancer	1.26e-06	4.57e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—KDR—breast cancer	1.26e-06	4.56e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—TYMS—breast cancer	1.26e-06	4.55e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—SRC—breast cancer	1.25e-06	4.55e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—ESR1—breast cancer	1.25e-06	4.54e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PLA2G4A—breast cancer	1.24e-06	4.5e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GSTM1—breast cancer	1.24e-06	4.5e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—NCOR1—breast cancer	1.24e-06	4.5e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—FN1—breast cancer	1.24e-06	4.49e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—ESR1—breast cancer	1.23e-06	4.44e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—SRC—breast cancer	1.22e-06	4.44e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NFKBIA—breast cancer	1.22e-06	4.43e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—VEGFA—breast cancer	1.22e-06	4.43e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PIK3CD—breast cancer	1.22e-06	4.43e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—SRC—breast cancer	1.22e-06	4.42e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—MAPK3—breast cancer	1.22e-06	4.41e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NOTCH1—breast cancer	1.21e-06	4.39e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—STAT3—breast cancer	1.21e-06	4.39e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—FN1—breast cancer	1.21e-06	4.39e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—SERPINE1—breast cancer	1.21e-06	4.38e-06	CbGpPWpGaD
Isoprenaline—PIK3R3—Signaling Pathways—AKT1—breast cancer	1.21e-06	4.38e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—IL6—breast cancer	1.21e-06	4.38e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Immune System—AKT1—breast cancer	1.21e-06	4.37e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NFKBIA—breast cancer	1.2e-06	4.34e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—KRAS—breast cancer	1.2e-06	4.34e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—VEGFA—breast cancer	1.19e-06	4.33e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—GPX1—breast cancer	1.19e-06	4.31e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NOTCH1—breast cancer	1.18e-06	4.3e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—APC—breast cancer	1.18e-06	4.29e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—KIT—breast cancer	1.18e-06	4.29e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PIK3CG—breast cancer	1.18e-06	4.29e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—STAT3—breast cancer	1.18e-06	4.28e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—PIK3CA—breast cancer	1.18e-06	4.27e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—STAT3—breast cancer	1.17e-06	4.26e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—EGF—breast cancer	1.17e-06	4.24e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ERCC2—breast cancer	1.17e-06	4.23e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—PIK3CA—breast cancer	1.16e-06	4.21e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—KIT—breast cancer	1.16e-06	4.2e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—APC—breast cancer	1.16e-06	4.2e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PIK3CG—breast cancer	1.16e-06	4.2e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—EGFR—breast cancer	1.16e-06	4.19e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MAPK3—breast cancer	1.16e-06	4.19e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—NOS3—breast cancer	1.15e-06	4.18e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Metabolism—AKT1—breast cancer	1.15e-06	4.17e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—EGF—breast cancer	1.14e-06	4.15e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—PIK3CA—breast cancer	1.14e-06	4.14e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—TP53—breast cancer	1.14e-06	4.13e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—MAPK3—breast cancer	1.13e-06	4.11e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MAPK3—breast cancer	1.13e-06	4.09e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—MYC—breast cancer	1.12e-06	4.08e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—TP53—breast cancer	1.12e-06	4.07e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—MAPK3—breast cancer	1.12e-06	4.07e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TGFB1—breast cancer	1.12e-06	4.07e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Disease—AKT1—breast cancer	1.11e-06	4.04e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—BRAF—breast cancer	1.11e-06	4.04e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—MAPK3—breast cancer	1.11e-06	4.02e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—EGFR—breast cancer	1.1e-06	3.99e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—PIK3CA—breast cancer	1.1e-06	3.98e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—MYC—breast cancer	1.1e-06	3.98e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—MTHFR—breast cancer	1.1e-06	3.98e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TGFB1—breast cancer	1.09e-06	3.97e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MDM2—breast cancer	1.09e-06	3.97e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—KRAS—breast cancer	1.09e-06	3.96e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—MYC—breast cancer	1.09e-06	3.96e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—RAF1—breast cancer	1.09e-06	3.95e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—HRAS—breast cancer	1.09e-06	3.95e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—TGFB1—breast cancer	1.09e-06	3.95e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—BRAF—breast cancer	1.09e-06	3.95e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—RELA—breast cancer	1.09e-06	3.94e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IGF1—breast cancer	1.08e-06	3.93e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—AKT2—breast cancer	1.08e-06	3.93e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—EGFR—breast cancer	1.08e-06	3.91e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—ERBB2—breast cancer	1.08e-06	3.91e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—HRAS—breast cancer	1.07e-06	3.89e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—EGFR—breast cancer	1.07e-06	3.89e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—EGFR—breast cancer	1.07e-06	3.87e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MTOR—breast cancer	1.06e-06	3.86e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PIK3CB—breast cancer	1.06e-06	3.86e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IGF1—breast cancer	1.06e-06	3.85e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—AKT2—breast cancer	1.06e-06	3.84e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—EGFR—breast cancer	1.06e-06	3.83e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—IL6—breast cancer	1.04e-06	3.78e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PIK3CD—breast cancer	1.04e-06	3.77e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—KRAS—breast cancer	1.04e-06	3.77e-06	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—PIK3CA—breast cancer	1.03e-06	3.74e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—SERPINE1—breast cancer	1.03e-06	3.73e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—IL6—breast cancer	1.03e-06	3.73e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CXCL8—breast cancer	1.02e-06	3.71e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—KRAS—breast cancer	1.02e-06	3.7e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PIK3CD—breast cancer	1.02e-06	3.69e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—HRAS—breast cancer	1.02e-06	3.69e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—KRAS—breast cancer	1.01e-06	3.68e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—CAV1—breast cancer	1.01e-06	3.67e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—KRAS—breast cancer	1.01e-06	3.66e-06	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—PIK3CA—breast cancer	1.01e-06	3.66e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—SERPINE1—breast cancer	1.01e-06	3.65e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—PIK3CA—breast cancer	1e-06	3.64e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CDKN1B—breast cancer	9.99e-07	3.62e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—KRAS—breast cancer	9.97e-07	3.62e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—NOS3—breast cancer	9.83e-07	3.56e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CASP3—breast cancer	9.79e-07	3.55e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IL2—breast cancer	9.78e-07	3.55e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—IL6—breast cancer	9.73e-07	3.53e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	9.67e-07	3.51e-06	CbGpPWpGaD
Isoprenaline—PIK3R2—Signaling Pathways—AKT1—breast cancer	9.62e-07	3.49e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—NOS3—breast cancer	9.61e-07	3.49e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—PIK3CA—breast cancer	9.55e-07	3.46e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CCND1—breast cancer	9.53e-07	3.46e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—JUN—breast cancer	9.51e-07	3.45e-06	CbGpPWpGaD
Isoprenaline—ADRBK1—Signaling Pathways—AKT1—breast cancer	9.48e-07	3.44e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CTNNB1—breast cancer	9.44e-07	3.42e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—PIK3CA—breast cancer	9.36e-07	3.4e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Metabolism—AKT1—breast cancer	9.33e-07	3.38e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MDM2—breast cancer	9.32e-07	3.38e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—PIK3CA—breast cancer	9.32e-07	3.38e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—RAF1—breast cancer	9.29e-07	3.37e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—HRAS—breast cancer	9.28e-07	3.37e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—PIK3CA—breast cancer	9.27e-07	3.36e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MMP9—breast cancer	9.25e-07	3.36e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—RELA—breast cancer	9.25e-07	3.36e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—TP53—breast cancer	9.23e-07	3.35e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—CDKN1A—breast cancer	9.22e-07	3.34e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PIK3CG—breast cancer	9.21e-07	3.34e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PTEN—breast cancer	9.2e-07	3.34e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—ERBB2—breast cancer	9.19e-07	3.33e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—PIK3CA—breast cancer	9.16e-07	3.32e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MDM2—breast cancer	9.12e-07	3.31e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—RAF1—breast cancer	9.09e-07	3.3e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PIK3CB—breast cancer	9.07e-07	3.29e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MTOR—breast cancer	9.07e-07	3.29e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—RELA—breast cancer	9.05e-07	3.28e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—TP53—breast cancer	9.01e-07	3.27e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MAPK8—breast cancer	9e-07	3.26e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—ERBB2—breast cancer	8.99e-07	3.26e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling by GPCR—AKT1—breast cancer	8.97e-07	3.25e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—IL6—breast cancer	8.89e-07	3.22e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MTOR—breast cancer	8.87e-07	3.22e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PIK3CB—breast cancer	8.87e-07	3.22e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—HRAS—breast cancer	8.83e-07	3.2e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CXCL8—breast cancer	8.72e-07	3.16e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—HRAS—breast cancer	8.66e-07	3.14e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—HRAS—breast cancer	8.62e-07	3.13e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—HRAS—breast cancer	8.57e-07	3.11e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—SRC—breast cancer	8.53e-07	3.09e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CXCL8—breast cancer	8.53e-07	3.09e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CDKN1B—breast cancer	8.51e-07	3.09e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—HRAS—breast cancer	8.47e-07	3.07e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—IL6—breast cancer	8.45e-07	3.07e-06	CbGpPWpGaD
Isoprenaline—ADRB1—GPCR downstream signaling—AKT1—breast cancer	8.42e-07	3.05e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CASP3—breast cancer	8.34e-07	3.03e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IL2—breast cancer	8.33e-07	3.02e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CDKN1B—breast cancer	8.33e-07	3.02e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—VEGFA—breast cancer	8.31e-07	3.01e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—IL6—breast cancer	8.29e-07	3.01e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—IL6—breast cancer	8.25e-07	2.99e-06	CbGpPWpGaD
Isoprenaline—ADRB2—GPCR downstream signaling—AKT1—breast cancer	8.24e-07	2.99e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—STAT3—breast cancer	8.23e-07	2.98e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—IL6—breast cancer	8.2e-07	2.98e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Immune System—AKT1—breast cancer	8.2e-07	2.97e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CASP3—breast cancer	8.16e-07	2.96e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IL2—breast cancer	8.15e-07	2.96e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CCND1—breast cancer	8.12e-07	2.95e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—IL6—breast cancer	8.11e-07	2.94e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—JUN—breast cancer	8.1e-07	2.94e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PIK3CD—breast cancer	8.1e-07	2.94e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CTNNB1—breast cancer	8.04e-07	2.92e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—ALB—breast cancer	8e-07	2.9e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CCND1—breast cancer	7.94e-07	2.88e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—JUN—breast cancer	7.93e-07	2.88e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MMP9—breast cancer	7.88e-07	2.86e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CTNNB1—breast cancer	7.87e-07	2.85e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MAPK3—breast cancer	7.86e-07	2.85e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—CDKN1A—breast cancer	7.86e-07	2.85e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PTEN—breast cancer	7.84e-07	2.84e-06	CbGpPWpGaD
Isoprenaline—PIK3R1—Signaling Pathways—AKT1—breast cancer	7.8e-07	2.83e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MMP9—breast cancer	7.71e-07	2.8e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—CDKN1A—breast cancer	7.69e-07	2.79e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MAPK8—breast cancer	7.67e-07	2.78e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PTEN—breast cancer	7.67e-07	2.78e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—NOS3—breast cancer	7.65e-07	2.77e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling by GPCR—AKT1—breast cancer	7.65e-07	2.77e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—MYC—breast cancer	7.64e-07	2.77e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TGFB1—breast cancer	7.62e-07	2.77e-06	CbGpPWpGaD
Isoprenaline—ADRB3—Signaling Pathways—AKT1—breast cancer	7.61e-07	2.76e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Disease—AKT1—breast cancer	7.57e-07	2.75e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MAPK8—breast cancer	7.5e-07	2.72e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling by GPCR—AKT1—breast cancer	7.48e-07	2.71e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—EGFR—breast cancer	7.48e-07	2.71e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—SRC—breast cancer	7.27e-07	2.64e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—SRC—breast cancer	7.11e-07	2.58e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—VEGFA—breast cancer	7.08e-07	2.57e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—KRAS—breast cancer	7.06e-07	2.56e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PIK3CB—breast cancer	7.06e-07	2.56e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—STAT3—breast cancer	7.01e-07	2.54e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PTGS2—breast cancer	7e-07	2.54e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—VEGFA—breast cancer	6.93e-07	2.51e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—STAT3—breast cancer	6.86e-07	2.49e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MAPK3—breast cancer	6.7e-07	2.43e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MAPK3—breast cancer	6.55e-07	2.38e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—MYC—breast cancer	6.51e-07	2.36e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TGFB1—breast cancer	6.5e-07	2.36e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—PIK3CA—breast cancer	6.49e-07	2.35e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—MYC—breast cancer	6.37e-07	2.31e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—EGFR—breast cancer	6.37e-07	2.31e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TGFB1—breast cancer	6.36e-07	2.31e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—TP53—breast cancer	6.28e-07	2.28e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—EGFR—breast cancer	6.23e-07	2.26e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PTEN—breast cancer	6.1e-07	2.21e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—KRAS—breast cancer	6.02e-07	2.18e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—HRAS—breast cancer	6e-07	2.18e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—KRAS—breast cancer	5.89e-07	2.14e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—IL6—breast cancer	5.75e-07	2.08e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—PIK3CA—breast cancer	5.53e-07	2.01e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—PIK3CA—breast cancer	5.41e-07	1.96e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—TP53—breast cancer	5.35e-07	1.94e-06	CbGpPWpGaD
Isoprenaline—MAPK1—Signaling Pathways—AKT1—breast cancer	5.3e-07	1.92e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—TP53—breast cancer	5.23e-07	1.9e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—HRAS—breast cancer	5.12e-07	1.86e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—HRAS—breast cancer	5e-07	1.82e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—IL6—breast cancer	4.9e-07	1.78e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—IL6—breast cancer	4.79e-07	1.74e-06	CbGpPWpGaD
Isoprenaline—ADRB1—Signaling Pathways—AKT1—breast cancer	4.52e-07	1.64e-06	CbGpPWpGaD
Isoprenaline—ADRB2—Signaling Pathways—AKT1—breast cancer	4.42e-07	1.6e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—PIK3CA—breast cancer	4.3e-07	1.56e-06	CbGpPWpGaD
Isoprenaline—CYP1A1—Metabolism—AKT1—breast cancer	3.52e-07	1.28e-06	CbGpPWpGaD
